Pigmentary disorders

Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligo affecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites.

 

  • Intensed Pulsed Light (IPL)Therapy
  • Lipokraft
  • Stem Cell Therapy
  • Genome Health Assessment

Related Conference of Pigmentary disorders

November 02-03, 2020

Asian Aesthetic and Dermatology Congress

Sydney, Australia
November 02-03, 2020

Global Meet on Skin Care and Plastic Aesthetics

Sydney, Australia
December 07-08, 2020

20th Global Dermatology Congress

Paris, France
December 07-08, 2020

5th World Dermatology, Trichology and Aesthetic Congress

Singapore City, Singapore
February 17-17, 2021

3rd Geriatrics and Healthcare Conference: For a better Aging Care

Kualalumpur, Malaysia
April 12-13, 2021

26th International Conference on Dermatology & Skin Care

Amsterdam, Netherlands
May 07-08, 2021

21st European Dermatology Congress

Amsterdam, Netherlands
June 21-22, 2021

22nd World Dermatology Congress

Tokyo, Japan
July 26-27, 2021

4th World Cosmetic and Dermatology Congress

London, UK

Pigmentary disorders Conference Speakers

Recommended Sessions

Related Journals

Are you interested in